International Journal of Medical Ophthalmology
Login   Signup

International Journal of Medical Ophthalmology

2021, Vol. 3 Issue 1, Part A
Clinical superiority of either of topical 0.5% apraclonidine, 0.2% brimonidine and 0.03% bimatoprost given prophylactically in managing intraocular pressure spikes following Nd:YAG laser posterior capsulotomy
Author(s): Tahir Husain Ansari, Pranav Gupta, Dr. Yusuf Rizvi and Mohd. Haroon Khan
Abstract:
Background: Extracapsular cataract extraction (ECCE) with implantation of posterior chamber intraocular lens (PC IOL) is currently the surgery of choice for cataract, with the success rate of over 95%.
Objectives: To earmark clinical superiority of either of the drugs given prophylactically in managing intraocular pressure spikes following Nd:YAG laser posterior capsulotomy.
Method: The present study was conducted on 100 patients, who had developed posterior capsule opacification following successful cataract surgery with intraocular lens implantation and underwent Nd:YAG laser posterior capsulotomy in the Outpatient Department of Ophthalmology, RMCH.
Results: In Apraclonidine group, pressure differences with control group were evident at 3 hours (ΔP3) & at 24 hours (ΔP24) that were highly statistically significant; (p=0.0078 & 0.0045 for ΔP3 & ΔP24 respectively). The same were not significantly different (p> 0.05) at 1 hour or day 7 following laser application. The Briminodine group demonstrated significant differences in pressure fluctuations compared with control group at all recorded times with maximum variation noted at 3 hours post capsulotomy (p=0.000015).
Conclusion: It was concluded Both Apraclonidine & Briminodine are found useful drug interventions in laser therapy, but Briminodine clearly scores over former in dampening the IOP rise.
Pages: 44-48  |  93 Views  46 Downloads
Download Full Article: Click Here
How to cite this article:
Tahir Husain Ansari, Pranav Gupta, Dr. Yusuf Rizvi, Mohd. Haroon Khan. Clinical superiority of either of topical 0.5% apraclonidine, 0.2% brimonidine and 0.03% bimatoprost given prophylactically in managing intraocular pressure spikes following Nd:YAG laser posterior capsulotomy. Int J Med Ophthalmol 2021;3(1):44-48. DOI: 10.33545/26638266.2021.v3.i1a.61
International Journal of Medical Ophthalmology